Clinical Trial Update: Use of a Cysteine-rich Whey Protein Isolate in Post COVID-19 Cognitive Impairment [NA]

View source ↗

Summary

This clinical trial update reports the completion of a study evaluating cysteine-rich whey protein isolate for post-COVID-19 cognitive impairment.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Post-acute Sequelae of Sars-cov-2 Infection

Drugs mentioned

• Cysteine-rich Whey Protein Isolate (cysteine-rich whey protein isolate)

Snippet

Sponsor: Universidad Libre seccional Cali | Conditions: COVID-19 (SARS-CoV-2 Infection) | NA | Status: COMPLETED